Cite
HARVARD Citation
Shi, B. et al. (n.d.). Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer. Cancer medicine. pp. 6383-6392. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shi, B. et al. (n.d.). Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer. Cancer medicine. pp. 6383-6392. [Online].